These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19490208)

  • 1. An open-label, randomized, 64-week study repeating 10- and 20-U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects.
    Kawashima M; Harii K
    Int J Dermatol; 2009 Jul; 48(7):768-76. PubMed ID: 19490208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects.
    Harii K; Kawashima M
    Aesthetic Plast Surg; 2008 Sep; 32(5):724-30. PubMed ID: 18663516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Rubin M; Dover J; Maas C; Nestor M
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S50-6. PubMed ID: 19945005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Baumann L; Brandt FS; Kane MA; Donofrio LM
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S57-65. PubMed ID: 19945006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Glabellar Contraction Patterns in Chinese and Efficacy of Botulinum Toxin Type A for Treating Glabellar Lines: A Pilot Study.
    Jiang H; Zhou J; Chen S
    Dermatol Surg; 2017 May; 43(5):692-697. PubMed ID: 28244900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Cohen JL; Schlessinger J; Cox SE; Lin X;
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S43-9. PubMed ID: 19945004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study.
    Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S
    J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A; Carruthers J; Said S
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study.
    Wu Y; Zhao G; Li H; Zheng Z; Zhong S; Yang Z; Feng Z; Yang Q; Zhu X
    Dermatol Surg; 2010; 36(1):102-8. PubMed ID: 20002637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of neutralizing antibody induction during treatment of glabellar lines with a new US formulation of botulinum neurotoxin type A.
    Lawrence I; Moy R
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S66-71. PubMed ID: 19945007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
    Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
    J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
    Beer KR
    Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program.
    Cohen JL; Green LJ; Beer KR; Liu Y; Gallagher CJ
    Dermatol Surg; 2021 Apr; 47(4):511-515. PubMed ID: 33587381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A; Carruthers J
    Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
    Kawashima M; Harii K; Horiuchi Y; Seidman E; Lei X; Hopfinger R; Lee E
    Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Increasing the Dose of Abobotulinumtoxina Impact the Duration of Effectiveness for the Treatment of Moderate to Severe Glabellar Lines?
    Joseph JH; Eaton LL; Robinson J; Pontius A; Williams EF
    J Drugs Dermatol; 2016 Dec; 15(12):1544-1549. PubMed ID: 29106437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection.
    Glogau R; Kontis TC; Liu Y; Gallagher CJ
    Dermatol Surg; 2021 Dec; 47(12):1579-1584. PubMed ID: 34417396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.
    Choi SY; Koh YG; Lee YW; Son HS; Yoon YN; Kim G; Won C; Cho H; Son JS; Kim EK; Kim BJ
    J Dermatolog Treat; 2024 Dec; 35(1):2359511. PubMed ID: 38880494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.